In this study, we found that DPI almost completely attenuated EGF-induced Akt phosphorylation at Ser473 in HT-29 cells. and time-dependent manners. Treatment of HT-29 cells with AG1478 (an EGF receptor (EGFR) inhibitor), small interfering RNA of EGFR (EGFR siRNA), a dominant unfavorable mutant of c-Src (c-Src DN), DPI (an NADPH oxidase inhibitor), glutathione (an ROS inhibitor), LY294002 (a PI3K inhibitor), and an Akt DN inhibited EGF-induced HO-1 expression. Activation of cells with EGF caused an increase in c-Src phosphorylation at Tyr406 in a time-dependent manner. Treatment NBI-74330 of HT-29 cells with EGF induced an increase in p47translocation from your cytosol to membranes. The EGF-induced ROS production was NBI-74330 inhibited by DPI. Activation of cells with EGF resulted in an increase in Akt phosphorylation at Ser473, which was inhibited by c-Src DN, DPI, and LY 294002. Moreover, treatment of HT-29 cells with a dominant unfavorable mutant of IB (IBM) inhibited EGF-induced HO-1 expression. Activation of cells with EGF induced p65 translocation from your cytosol to nuclei. Treatment of HT-29 cells with EGF induced an increase in B-luciferase activity, which was inhibited by a c-Src DN, LY 294002, and an Akt DN. Furthermore, EGF-induced colon cancer cell proliferation was inhibited by Sn(IV)protoporphyrin-IX (snPP, an HO-1 inhibitor). Taken together, these results suggest that the c-Src, NADPH oxidase, PI3K, and Akt signaling pathways play important functions in EGF-induced NF-B activation and HO-1 expression in HT-29 cells. Moreover, overexpression of HO-1 mediates EGF-induced colon cancer cell proliferation. Introduction Approximately one million cases of colon cancer are diagnosed worldwide each year, and an increasing pattern in the incidence of colon cancer in Asian countries was reported in recent years [1]. Previous reports indicated that the intake of red and processed meats is usually associated with an increased risk NBI-74330 of colorectal malignancy because red meat contains approximately 10-fold higher levels of heme than white meat [2]. Heme oxygenase (HO) plays vital functions in physiological iron homeostasis, antioxidant defense, and malignancy cell proliferation [3]. HO catalyzes the conversion of heme to biliverdin, releasing equimolar amounts of carbon monoxide, and concomitant induction of iron-sequestering ferritin [4]. Three isoforms of HO (HO-1, -2, and -3) were recognized [5]. HO-1 is an inducible enzyme caused by growth factors including transforming growth factor (TGF)- and epidermal growth factor (EGF), reflecting the main role of this enzyme in protecting against oxidative injury [6], [7]. Moreover, HO-1 is usually often highly upregulated in colon cancer compared to surrounding normal tissue, suggesting that malignancy cells highly expressing HO enjoy a growth advantage and provide cellular resistance against reactive oxygen species (ROS)-mediated anticancer therapies [8]C[10]. The importance of EGF in the development of colon cancer was emphasized in recent years [11]. A growing body of evidence suggests that EGF regulates multiple biological functions such as cancer cell Rabbit polyclonal to ITGB1 progression, cell proliferation, and metastasis [11]. The EGF receptor (EGFR) was shown to participate in colon cancer development [11]. EGF binds to the extracellular domain name of the EGFR which activates downstream signaling pathways including the c-Src and phosphatidyl inositol 3-kinase (PI3K)/Akt pathways [12], [13]. A previous statement indicated that overexpression of HO-1 plays a protective role in attenuating cellular damage and malignancy cell survival [6], [7]. However, little is known about how EGF regulates the induction of HO-1 protein expression. Expression of the gene is usually primarily regulated at the transcription level by activating transcription factors including nuclear factor (NF)-B, activating protein (AP)-2, and the heat shock-responsive element (HSE) [14], [15]. NF-B is an important transcription factor for regulating HO-1 expression [16]. At rest, NF-B binding to IB prevents NF-B nuclear translocation and transcription activity [17]. However, growth factors induce IB kinase (IKK) activation, IB phosphorylation, and IB degradation. This process releases active NF-B, which is usually then translocated from your cytosol to nuclei, to bind the HO-1 NBI-74330 promoter region NBI-74330 and induce gene expression [16], [18]. Several reports showed that EGF-induced.